Immune System Disorder Clinical Trial
Official title:
Aerobic Training Combined With Diet Protocol on Immune System in Burn Patients.
Aerobic exercises can produce immediate and short-term improvements in the immune response of leukocytes, T-lymphocytes, lymphocyte subpopulations, interleukins, and immunoglobulins. Even only a single session of aerobic exercises produces improvements in the utmost immune markers, such as T-lymphocytes, leukocytes, and immunoglobulins. Also, burned patients suffer from post-traumatic stress and stress can cause this alteration through its effect on increasing the amounts of serum corticosteroid and catecholamine hormones, thus a decrease in the immunity response might occur. Increasing the aerobic capacity can significantly improve the mood. This might be attributed to the effect of aerobic exercises on decreasing stress hormones, like corticosteroids and catecholamines hormones. The altered metabolism post major burn also affects the immune system in burn patients and the aerobic training enhances the metabolism, body composition and the lean mass and so, enhances the immune system. One of the most important factors for a good and effective immune system is the balanced diet especially diet rich in vitamin D, fibers, and multiple nuts and seeds such as almond, walnut, pistachio, sunflower seeds, flax seeds and sesame seed that have an crucial role in improving the immune system either acting on it directly or indirectly by enhancing the general heath of the body and the patients mood.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | May 19, 2024 |
Est. primary completion date | February 19, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 40 Years |
Eligibility | Inclusion Criteria: - Patients from both genders. - The age ranges from 25 to 40 years. - Weight range 60-85 kg, height 155- 170 cm. - Total burned surface area (TBSA) was 20- 40% measured by the rule of nines. - Thermal burn. - Burn depth, partial-thickness burn injury. - Patient will participate in the study one month after discharge. Exclusion Criteria: - Inhalation injury. - Leg amputation. - Any limitation in LL range of motion. - Auditory or visual problems. - Congenital musculoskeletal deformities, especially in the foot. - Psychiatric disorders. - Paralysis. - Cardiac abnormalities or cardiac pacemakers. - Patients who participated in any rehabilitation program before the study that may affect our results. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Physical therapy, Cairo University | Giza |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The immune markers | total lymphocyte count (TLC) in 10^9 cells/liter will be measured | Three months | |
Primary | Neutrophil to lymphocyte ratio (NLR) | The immune markers | Three months | |
Primary | Platelet to lymphocyte ratio (PLR) | The immune markers | Three months | |
Secondary | The Arabic version of post traumatic stress disorder PTSD Checklist Civilian Version | It is a 17-item self-report scale that measures PTSD symptom severity | Three months | |
Secondary | The quality of life (QoL) | Burn Specific Health Scale-Brief (BSHS-B) questionnaire will be used for the assessment of general, physical, mental, and social health aspects of the burn survivors | Three months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04430972 -
Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
|
||
Not yet recruiting |
NCT04830046 -
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
|
||
Recruiting |
NCT04928963 -
Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly.
|
Phase 1/Phase 2 | |
Recruiting |
NCT05507242 -
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
|
Phase 2 | |
Completed |
NCT03385850 -
The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis
|
N/A | |
Completed |
NCT03744676 -
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
|
Phase 2 | |
Recruiting |
NCT03908736 -
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
|
N/A | |
Completed |
NCT04386395 -
Immune Changes in Severe COVID-19 Pulmonary Infections
|
||
Active, not recruiting |
NCT06060509 -
Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia Population
|
N/A | |
Recruiting |
NCT04444609 -
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
|
||
Terminated |
NCT04294459 -
Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT06314451 -
Cross-condition Validation of the Steroid PRO
|
||
Completed |
NCT05000307 -
Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection
|
N/A | |
Active, not recruiting |
NCT06107348 -
COVID-19 Post-Vaccination Observation
|
||
Recruiting |
NCT05139706 -
Montreal Immune-Related Adverse Events (MIRAE) Study
|
||
Withdrawn |
NCT05219890 -
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
|
N/A | |
Completed |
NCT03357939 -
Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT05002023 -
PRINCE Study - Cohort Study of Healthy Pregnant Women Followed by the Assessment of Children´s Health and Immunity
|
||
Recruiting |
NCT05266664 -
Preterm Immune System Development and Response to Immunization
|
||
Active, not recruiting |
NCT04802044 -
COVID-19, Aging, and Cardiometabolic Risk Factors Study
|